Affiliation:
1. Department of Anesthesiology, Far-Eastern Memorial Hospital, Pan-Chiao District, New Taipei City, Taiwan, China
2. Graduate Institute of Basic Medicine, Fu Jen Catholic University, No.510, Zhongzheng Rd., Xinzhuang Dist., New
Taipei City, Taiwan, China
Abstract
Background:
Regulation of glutamate release is crucial for maintaining normal brain
function, but excess glutamate release is implicated in many neuropathological conditions. Therefore,
the minimum glutamate release from presynaptic nerve terminals is an important neuroprotective
mechanism.
Objective:
In this mini-review, we analyze the three B vitamins, namely vitamin B2 (riboflavin), vitamin
B6 (pyridoxine), and vitamin B12 (cyanocobalamin), that affect the 4-aminopyridine (4-
AP)-evoked glutamate release from presynaptic nerve terminal in rat and discuss their neuroprotective
role.
Methods:
In this study, the measurements include glutamate release, DiSC3(5), and Fura-2.
Results:
The riboflavin, pyridoxine, and cyanocobalamin produced significant inhibitory effects on
4-aminopyridine-evoked glutamate release from rat cerebrocortical nerve terminals (synaptosomes)
in a dose-dependent relationship. These presynaptic inhibitory actions of glutamate release are attributed
to inhibition of physiologic Ca2+-dependent vesicular exocytosis but not Ca2+-independent
nonvesicular release. These effects also did not affect membrane excitability, while diminished cytosolic
(Ca2+)c through a reduction of direct Ca2+ influx via Cav2.2 (N-type) and Cav2.1 (P/Q-type)
Ca2+ channels, rather than through indirect Ca2+ induced Ca2+ release from ryanodine-sensitive intracellular
stores. Furthermore, their effects were attenuated by GF109203X and Ro318220, two protein
kinase C (PKC) inhibitors, suggesting suppression of PKC activity. Taken together, these results
suggest that riboflavin, pyridoxine, and cyanocobalamin inhibit presynaptic vesicular glutamate
release from rat cerebrocortical synaptosomes, through the depression Ca2+ influx via voltage-
dependent Cav2.2 (N-type) and Cav2.1 (P/Q-type) Ca2+ channels, and PKC signaling cascade.
Conclusion:
Therefore, these B vitamins may reduce the strength of glutamatergic synaptic transmission
and is of considerable importance as potential targets for therapeutic agents in glutamate-
induced excitation-related diseases.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,General Neuroscience
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献